Inhibition of the Hepatitis C Virus NS3 Protease Activity by Fv Fragment of Antibody 8D4
- 23 February 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 281 (2) , 416-424
- https://doi.org/10.1006/bbrc.2001.4382
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Peptide Design Based on an Antibody Complementarity-Determining Region (CDR): Construction of Porphyrin-Binding Peptides and Their Affinity Maturation by a Combinatorial MethodChemistry – A European Journal, 2000
- Isolation and Characterization of Monoclonal Antibodies That Inhibit Hepatitis C Virus NS3 ProteaseJournal of Virology, 2000
- The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapyJournal of Viral Hepatitis, 1999
- Synthetic Peptides Derived from the Variable Regions of an Anti-CD4 Monoclonal Antibody Bind to CD4 and Inhibit HIV-1 Promoter Activation in Virus-infected CellsJournal of Biological Chemistry, 1999
- Recombinant antibody fragmentsCurrent Opinion in Biotechnology, 1998
- Peptides Derived from the Complementarity-determining Regions of Anti-Mac-1 Antibodies Block Intercellular Adhesion Molecule-1 Interaction with Mac-1Journal of Biological Chemistry, 1998
- Novel selection method for engineered antibodies using the mechanism of Fv fragment stabilization in the presence of antigenProtein Engineering, Design and Selection, 1997
- Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.Proceedings of the National Academy of Sciences, 1992
- Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.Proceedings of the National Academy of Sciences, 1990
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989